Drug intelligence / Profile preview

Vichy Dercos Aminexil Clinical 5

Development stage
Unknown
Lead developer
L'Oréal
Modality
Small Molecules
Administration
Topical
01

Overview

Vichy Dercos Aminexil Clinical 5 is a topical combination product developed by L'Oréal Research and Innovation to treat mild to moderate alopecia (hair loss), particularly for individuals with sensitive scalps. [8] The formulation contains three key components: piroctone olamine, 2,4-diaminopyrimidine oxide (also known as aminexil), and Vichy's proprietary mineralizing thermal water. Piroctone olamine provides antifungal properties to improve overall scalp health and balance. [1, 4] Aminexil, a molecule patented by L'Oréal, works by counteracting perifollicular fibrosis (the hardening of collagen around hair roots), which helps to anchor the hair more securely to the scalp. [11, 12, 19] The Vichy Mineralizing Water component provides soothing and strengthening benefits to the scalp. [8] The product is marketed as a cosmetic treatment that reduces hair loss, strengthens hair fibers, and improves scalp resistance. [3, 8, 13]

Brand names
Vichy Dercos Aminexil Clinical 5Vichy Dercos Aminexil Clinical
Other names
pirotone olamine + 2,4-diaminopyrimidine oxide + Vichy Mineralizing Water
02

Targets

SUR2B (Sulfonylurea receptor 2B)

Beyond the preview

Go deeper on Vichy Dercos Aminexil Clinical 5.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vichy Dercos Aminexil Clinical 5.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call